The successful development of animal models of inherited human diseases generally requires a multidisciplinary approach, involving clinicians, geneticists, biochemists, veterinary pathologists, human pathologists and other specialists. The study of disease mechanisms naturally encompasses many disciplines and thus, the pathology laboratory provides some of the more essential services in support of these common goals.
The specific aims of the Pathology Core in this Program Project are to: (i) Provide gross and microscopic pathology support as needed for all of the projects described in the Program Project. These activities will provide information of crucial importance in analysis of gene targeted organs/systems and for evaluation of unexpected deaths due to developmental or other defects. (ii) Provide a wide range of specialized pathology methods such as in situ hybridization (ISH), immunofluorescence (IFA), immunohistochemistry, ultrastructural studies, hematologic analyses and others, which will be required by most of the projects in this Program Project at some stage in development and analysis of their models. These services will be provided by certified veterinary pathologists (ACVP) and a well qualified research assistant (HT, HTL-ASCP), with the advice and consultation of selected consultants as needed in the establishment or development of additional new procedures. The Animal Diagnostic/Health Surveillance Laboratory in the Department of Comparative Medicine of the University of Alabama at Birmingham has more than twenty- five years of experience in animal model development and in provision of many of the services of this Pathology Core.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Program Projects (P01)
Project #
5P01RR011105-02
Application #
5225935
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Elgavish, Ada; Wood, Philip A; Pinkert, Carl A et al. (2004) Transgenic mouse with human mutant p53 expression in the prostate epithelium. Prostate 61:26-34
Fukuchi, K; Hart, M; Yan, Z et al. (2004) Transgenic mice overexpressing both amyloid beta-protein and perlecan in pancreatic acinar cells. Histol Histopathol 19:845-52
Yancey, A L; Watson, H L; Cartner, S C et al. (2001) Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect Immun 69:2865-71
Hart, M; Li, L; Tokunaga, T et al. (2001) Overproduction of perlecan core protein in cultured cells and transgenic mice. J Pathol 194:262-9
Kurtz, D M; Tian, L; Gower, B A et al. (2000) Transgenic studies of fatty acid oxidation gene expression in nonobese diabetic mice. J Lipid Res 41:2063-70
Fukuchi, K; Li, L; Hart, M et al. (2000) Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor. Int J Exp Pathol 81:231-9
Cartner, S C; Lindsey, J R; Gibbs-Erwin, J et al. (1998) Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun 66:3485-91
Li, L; Perry, R; Wu, J et al. (1998) Polymorphic tetranucleotide repeat site within intron 7 of the beta-amyloid precursor protein gene and its lack of association with Alzheimer's disease. Hum Genet 103:86-9
Fukuchi, K; Pham, D; Hart, M et al. (1998) Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am J Pathol 153:1687-93
Fukuchi, K; Hart, M; Li, L (1998) Alzheimer's disease and heparan sulfate proteoglycan. Front Biosci 3:d327-37

Showing the most recent 10 out of 13 publications